Subunit-selective modulation of GABAA receptors by the non-steroidal anti-inflammatory agent, mefenamic acid

European Journal of Neuroscience

Volumn 11, Issue 8, 1999, Pages 2897-2905

  Halliwell, R F ^a   Thomas, P ^c   Patten, D ^a   James, C H ^c   Martinez Torres, A ^b   Miledi, R ^b   Smart, T G ^c  

^a DURHAM UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Asparagine 290; Fenamates; Human recombinant receptors; Molecular model; TM2; receptor subunits

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ASPARAGINE; DIAZEPAM; ETOMIDATE; FLUMAZENIL; IBUPROFEN; INDOMETACIN; LORECLEZOLE; MEFENAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOBARBITAL; RECEPTOR SUBUNIT; RECOMBINANT RECEPTOR; SERINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; KIDNEY CELL; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; RECEPTOR UPREGULATION; XENOPUS;

AMINO ACID SEQUENCE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; ELECTRIC CONDUCTIVITY; ELECTROPHYSIOLOGY; ETOMIDATE; HUMANS; MEFENAMIC ACID; MODELS, MOLECULAR; MOLECULAR CONFORMATION; OOCYTES; PROTEIN ISOFORMS; RECEPTORS, GABA-A; RECOMBINANT PROTEINS; TRIAZOLES; XENOPUS LAEVIS;

EID: 0032866803     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.1999.00709.x     Document Type: Article

References (42)

1. Akaike, N., Hattori, K., Inomata, N. & Oomura, Y. (1985) γ-Aminobutyric acid- and pentobarbitone-gated chloride currents in internally perfused frog sensory neurones. J. Physiol. (Lond.), 360, 367-386.
2. Bannwarth, B., Netter, P., Pourel, J., Royer, R.J. & Gaucher, A. (1989) Clinical pharmacokinetics of nonsteroidal anti-inflammatory drugs in the cerebrospinal fluid. Biomed. Pharmacother., 43, 121-126.
3. Belelli, D., Lambert, J.J., Peters, J.A., Wafford, K.A. & Whiting, P.J. (1997) The interaction of the general anaesthetic etomidate with the γ-aminobutyric acid type A receptor is influenced by a single amino acid. Proc. Natl Acad. Sci. USA, 94, 11031-11036.
4. A receptor. J. Membr. Biol., 155, 157-166.
5. min channel complex. Trends Pharmacol. Sci., 18, 26-29.
6. Chen, Q., Olney, J.W., Lukasiewicz, P.D., Almli, T. & Romano, C. (1998) Fenamates protect neurons against ischemic and excitoxic injury in chick embryo retina. Neurosci. Letts., 242, 163-166.
7. A receptors is determined by receptor β subunits. Proc. Natl Acad. Sci. USA, 93, 9899-9904.
8. Cryer, B. & Feldman, M. (1998) Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am. J. Med., 104, 413-421.
9. A receptor subunit. Nature, 385, 820-823.
10. A receptors comprised of α1β3 and β3 subunits expressed in human embryonic kidney 293 cells. Br. J. Pharmacol., 120, 899-909.
11. Evonuik, G. & Skolnick, P. (1988) Picrate and niflumate block anion modulation of radioligand binding to the γ-aminobutyric acid/ benzodiazepine receptor complex. Mol. Pharmacol., 34, 837-842.
12. Frolich, J.C. (1997) A classification of NSAIDs according to the relative inhibition of cyclo-oxygenase isoenzymes. Trends Pharmacol. Sci., 18, 30-34.
13. Gogelein, H., Dahlem, D., Englert, H.C. & Lang, H.J. (1990) Flufenamic acid, mefenamic acid and niflumic acid inhibit single nonselective cation channels in the rat exocrine pancreas. FEBS Lett., 268, 79-82.
14. Gossinger, H., Hruby, K., Haubenstock, A., Jung, M. & Zwerina, N. (1982) Coma in mefenamic acid poisoning. Lancet, 8294, 384.
15. Greenwood, I.A. & Large, W.A. (1995) Comparison of the effects of fenamates on Ca-activated chloride and potassium currents in rabbit portal vein smooth muscle cells. Br. J. Pharmacol., 116, 2939-2948.
16. A receptors by the NSAID mefenamic acid. Br. J. Pharmacol., 125, 26P.
17. Hendrickse, M.T. (1988) Mefenamic acid overdose mimicking brainstem stroke. Lancet, 8618, 1019.
18. Hill-Venning, C., Belelli, D., Peters, J.A. & Lambert, J.J. (1997) Subunit-dependent interaction of the general anaesthetic etomidate with the γ-aminobutyric acid type A receptor. Br. J. Pharmacol., 120, 749-756.
19. Ikonomidou-Turski, C., Cavalheiro, E.A., Turski, L., Bortolotto, Z.A., Kleinrok, Z., Calderazzo-Filho, L.S. & Turski, W.A. (1988) Differential effects of non-steroidal anti-inflammatory drugs on seizures produced by pilocarpine in rats. Brain Res., 462, 275-285.
20. Jung, F., Selvaraj, S. & Gargus, J.J. (1992) Blockers of platelet-derived growth factor-activated non-selective cation channels inhibit cell proliferation. Am. J. Physiol., 262, C1464-C1470.
21. Koradi, R., Billeter, M. & Wethrich, K. (1996) MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graphics, 14, 51-55.
22. A receptor-ion channels: evaluation of pharmacological and physiological properties. Mol. Pharmacol., 49, 494-504.
23. Lerma, J. & Del Rio, R.M. (1992) Chloride transport blockers prevent N-methyl-D-aspartate receptor-channel complex activation. Mol. Pharmacol., 41, 217-222.
24. Malmberg, A.B. & Yaksh, T.L. (1992) Hyperalgesia mediated by spinal glutamate or substance P blocked by spinal cyclooxygenase inhibitors. Science, 257, 1276-1279.
25. McCormack, K. (1994) Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain, 59, 9-41.
26. McGeer, P.L., Schulzer, M. & McGeer, E.G. (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheifner's disease: a review of 17 epidemiological studies. Neurology, 47, 425-432.
27. A-gated chloride channel by pentobarbitone and mefenamic acid. Soc. Neurosci. Abstr., 23, 49.7, 104.
28. A receptor research. Synapse, 21, 189-274.
29. A chloride channels in mammalian dorsal root ganglion neurones. Br. J. Pharmacol., 98, 167-176.
30. Smolinske, S.C., Hall, A.H., Vandenberg, S.A., Spoerke, D.G. & McBride, P.V. (1990) Toxic effects of non-steroidal anti-inflammatory drugs in overdose: an overview of recent evidence on clinical effects and dose-response relationships. Drug Safety, 5, 252-274.
31. A receptors by mefenamic acid: involvement of asparagine 290 in the second transmembrane domain of the β2 subunit. Br. J. Pharmacol., 125, 42P.
32. Vane, J.R. (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature, 231, 232-235.
33. Vane, J.R. & Botting, R.M. (1996) Mechanisms of action of anti-inflammatory drugs. Scand. J. Rheumatol. Suppl., 102, 9-21.
34. A receptor β subunit. Neuron, 12, 775-782.
35. Wallenstein, M.C. (1991) Attenuation of epileptogenesis by non-steroidal anti-inflammatory drugs in the rat. Neuropharmacology, 30, 657-663.
36. 2+-activated CP channels in Xenopus oocytes. Mol. Pharmacol., 37, 720-724.
37. Whittemore, E.R., Yang, W., Drewe, J.A. & Woodward, R.M. (1996) Pharmacology of the human γ-aminobutyric acid type A receptor α4 subunit expressed in Xenopus laevis oocytes. Mol. Pharmacol., 50, 1364-1375.
38. Wingrove, P.B., Wafford, K.A., Bain, C. & Whiting, P.J. (1994) The modulatory action of loreclezole at the γ-aminobutyric acid type A receptor is determined by a single amino acid in the β2 and β3 subunit. Proc. Natl Acad. Sci. USA, 91, 4569-4573.
39. A receptors expressed in Xenopus oocytes. J. Pharm. Exp. Ther., 268, 806-817.
40. A receptors. Eur. J. Neurosci., 9, 2225-2235.
41. A receptor α1 subunit. J. Gen. Physiol., 107, 195-205.
42. Zwart, R., Oortgiesen, M. & Vijverberg, H.P.M. (1995) Differential modulation of α3β2 and α3β4 neuronal nicotinic receptors expressed in Xenopus oocytes by flufenamic acid and niflumic acid. J. Neurosci., 15, 2168-2178.